Literature DB >> 9746017

Not much progress in treatment of cerebral malaria.

N J White1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9746017     DOI： 10.1016/s0140-6736(05)79572-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria.

Authors:  T T Hien; T M E Davis; L V Chuong; K F Ilett; D X T Sinh; N H Phu; C Agus; G M Chiswell; N J White; J Farrar
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

2.  Malaria at Christmas: risks of prophylaxis versus risks of malaria.

Authors:  A J Reid; C J Whitty; H M Ayles; R M Jennings; B A Bovill; J M Felton; R H Behrens; A D Bryceson; D C Mabey
Journal:  BMJ       Date:  1998-11-28

3.  Rosiglitazone modulates the innate immune response to Plasmodium falciparum infection and improves outcome in experimental cerebral malaria.

Authors:  Lena Serghides; Samir N Patel; Kodjo Ayi; Ziyue Lu; D Channe Gowda; W Conrad Liles; Kevin C Kain
Journal:  J Infect Dis       Date:  2009-05-15       Impact factor: 5.226

Review 4.  Drug treatment of tropical parasitic infections: recent achievements and developments.

Authors:  I Stephenson; M Wiselka
Journal:  Drugs       Date:  2000-11       Impact factor: 11.431

Review 5.  Severe malarial anemia: innate immunity and pathogenesis.

Authors:  Douglas J Perkins; Tom Were; Gregory C Davenport; Prakasha Kempaiah; James B Hittner; John Michael Ong'echa
Journal:  Int J Biol Sci       Date:  2011-11-02       Impact factor: 6.580

6.  C5 deficiency and C5a or C5aR blockade protects against cerebral malaria.

Authors:  Samir N Patel; Joanne Berghout; Fiona E Lovegrove; Kodjo Ayi; Andrea Conroy; Lena Serghides; Gundula Min-oo; D Channe Gowda; J Vidya Sarma; Daniel Rittirsch; Peter A Ward; W Conrad Liles; Philippe Gros; Kevin C Kain
Journal:  J Exp Med       Date:  2008-04-21       Impact factor: 14.307

7.  Precision identification of high-risk phenotypes and progression pathways in severe malaria without requiring longitudinal data.

Authors:  Iain G Johnston; Till Hoffmann; Nick S Jones; Climent Casals-Pascual; Sam F Greenbury; Ornella Cominetti; Muminatou Jallow; Dominic Kwiatkowski; Mauricio Barahona
Journal:  NPJ Digit Med       Date:  2019-07-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.